Menu visibility control

Video

Events

Startup Surgery

Most Recent

Government & Policy

Here’s how UK tech reacted to the Supreme Court’s Brexit ruling

Investments

Wiltshire-based HealthTech firm Atlas Genetics closes $35m Series D

Investments

Leeds-based online sports network Pitchero lands £3.1m Series A

Press Releases

Starling Bank first of digital challengers to join Faster Payments as direct partner
No more electronic ‘loose change’: innovative fintech charity payment scheme launched today across 6,000 UK schools
Chimni calls for the UK proptech community to work more closely with the housebuilding industry

Bristol-based Micrima raises £2.6m to improve breast screening

breast screening
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Micrima, a Bristol-based breast imaging tech company, has raised £2.6m in funding from pre-existing and new investors.

Founded in 2006, the company’s patented MARIA technology aims to make breast screening safer, more comfortable and more accessible to a larger proportion of the female population.

The round drew in support from re-investing shareholders including Technology Venture Partners LLP, Swarraton Partners, and the Angel CoFund. The University of Bristol Enterprise Fund has been welcomed as a new investor.

How to secure funding from Tim Mills, investment director at the Angel CoFund

Roy Johnson, founder and executive chairman of Micrima, said: “Breast cancer is the most common cause of death in women between the ages of 35 and 55 in Europe and the leading cause of death for women in many countries. The problem is that many tumours are not discovered early enough, largely due to the difficulty in discriminating between cancers and dense tissue using current imaging technology.”

The firm says it will use the funding to support accelerated development of its MARIA technology, initially pioneered at the University of Bristol, with plans to start the commercialisation of its first system towards the end of this year.

“Using harmless radiowaves, the MARIA imaging system is capable of detecting tumours in dense tissue and allows routine and repeated scanning without any of the safety or comfort concerns associated with x-ray mammography. The process takes less than five minutes and avoids painful breast compression,” Johnson continued.

Tim Mills, investment director at the Angel CoFund, commented: “We originally invested in Micrima because we knew we’d found an extremely capable team working with some very interesting technology in a sector with considerable opportunity for innovation. The team has really delivered on our expectation in the last couple of years and we’re very happy to be supporting them again through this next phase of development.”

Enter your e-mail address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

Supreme Court

Here’s how UK tech reacted to the Supreme Court’s Brexit ruling
posted 7 hours ago

HealthTech

Wiltshire-based HealthTech firm Atlas Genetics closes $35m Series D
posted 8 hours ago

pitchero

Leeds-based online sports network Pitchero lands £3.1m Series A
posted on January 23, 2017

PM Theresa May

UK tech community reacts to Theresa May’s Industrial Strategy proposals
posted on January 23, 2017

Theresa May

PM Theresa May to reveal Industrial Strategy Challenge Fund to support UK tech
posted on January 23, 2017

Tech for good

Here’s how tech for good startups can maximise their chances of getting funded
posted on January 23, 2017